In women with MS, secretion of cytokines, such as interleukin-10, activin-A and programmed death ligand-1 (PD-L1), induces a tolerogenic status towards the foeto-placental unit and likewise suppresses MS activity [32]. This evidence concerns the gene IL10 and myeloid sarcoma.